Terpene trilactones from Gingko biloba: from ancient times to the 21st century.
暂无分享,去创建一个
[1] K. Nakanishi,et al. Ginkgolides: selective acetylations, translactonization, and biological evaluation. , 2002, The Journal of organic chemistry.
[2] A. Schatzberg,et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. , 1997, JAMA.
[3] A. Wieraszko,et al. Platelet activating factor (PAF) in memory formation: role as a retrograde messenger in long-term potentiation. , 1996, Journal of lipid mediators and cell signalling.
[4] J. Buccafusco,et al. Multiple central nervous system targets for eliciting beneficial effects on memory and cognition. , 2000, The Journal of pharmacology and experimental therapeutics.
[5] Kunio Kato,et al. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation , 1994, Nature.
[6] O. Krishtal,et al. Inhibition of hippocampal LTP by ginkgolide B is mediated by its blocking action on PAF rather than glycine receptors , 2004, Neurochemistry International.
[7] G. Toubin,et al. The effect of ginkgo biloba extract on free radical production in hypoxic rats. , 2001, Biological & pharmaceutical bulletin.
[8] K. Nakanishi,et al. Structure of bilobalide, a rare tert-butyl containing sesquiterpenoid related to the C20-ginkgolides , 1971 .
[9] R. C. Mehrotra,et al. Reaction of silicon tetrachloride with tertiary butyl acetate. A novel synthesis of silicon tetraacetate , 1963 .
[10] K. Nakanishi,et al. The ginkgolides. II Derivation of partial structures , 1967 .
[11] K. Weinges,et al. Chemie der Ginkgolide, II. Isolierung und Strukturaufklärung eines neuen Ginkgolids , 1987 .
[12] S. Matsuda,et al. Cloning and characterization of Ginkgo biloba levopimaradiene synthase which catalyzes the first committed step in ginkgolide biosynthesis. , 2001, Archives of biochemistry and biophysics.
[13] K. Kato. Modulation of long-term potentiation in the CA1 area of rat hippocampus by platelet-activating factor. , 1999, Advances in experimental medicine and biology.
[14] T. Itil,et al. Natural substances in psychiatry (Ginkgo biloba in dementia). , 1995, Psychopharmacology bulletin.
[15] T. Manabe,et al. Platelet‐activating factor receptor is not required for long‐term potentiation in the hippocampal CA1 region , 1999, The European journal of neuroscience.
[16] A. Kriegstein,et al. Terpene Trilactones from Ginkgo biloba Are Antagonists of Cortical Glycine and GABAA Receptors* , 2003, Journal of Biological Chemistry.
[17] K. Nakanishi,et al. Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists. , 2003, Journal of medicinal chemistry.
[18] E. Rüther,et al. Prescribing practice with cognition enhancers in outpatient care: are there differences regarding type of dementia?--Results of a representative survey in lower Saxony, Germany. , 2007, Pharmacopsychiatry.
[19] D. Kennedy,et al. The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers , 2000, Psychopharmacology.
[20] 中西 香爾,et al. Comprehensive natural products chemistry , 1999 .
[21] P. D. Tredici. THE EVOLUTION, ECOLOGY, AND CULTIVATION OF GINKGO BILOBA , 2000 .
[22] K. Nakanishi,et al. Ginkgolides and glycine receptors: a structure-activity relationship study. , 2004, Chemistry.
[23] Katsunori Tanaka,et al. Preparation of ginkgolide and F-seco-ginkgolide lactols: the unique reactivity of α-hydroxy lactones toward NaBH4 , 2005 .
[24] S. Ishii,et al. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. , 2000, Progress in lipid research.
[25] P. Schultz,et al. The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] K. Nakanishi,et al. Biosynthesis of ginkgolide B, its diterpenoid nature, and origin of the tert-butyl group , 1971 .
[27] Paul F. Smith,et al. PLATELET-ACTIVATING FACTOR IN THE CNS , 1996, Progress in Neurobiology.
[28] Turan M. Itil,et al. A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia , 1997 .
[29] A. Ogura,et al. Platelet-activating factor (PAF) receptor in rat brain: PAF mobilizes intracellular Ca2+ in hippocampal neurons , 1992, Neuron.
[30] P. Houghton,et al. MEDICINAL AND AROMATIC PLANTS INDUSTRIAL PROFILE , 1996 .
[31] S. Chatterjee,et al. Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba , 1997, Brain Research.
[32] J. V. Smith,et al. Studies on molecular mechanisms of Ginkgo biloba extract , 2004, Applied Microbiology and Biotechnology.
[33] T. V. van Beek,et al. Quantitation of bilobalide and ginkgolides A, B, C and J by means of nuclear magnetic resonance spectroscopy. , 1993 .
[34] K. Nakanishi,et al. Chemistry and biology of terpene trilactones from Ginkgo biloba. , 2004, Angewandte Chemie.
[35] J. Polich,et al. Cognitive effects of a Ginkgo biloba/vinpocetine compound in normal adults: systematic assessment of perception, attention and memory , 2001, Human psychopharmacology.
[36] J. Doucet,et al. Excitable membranes, lipid messengers, and immediate-early genes , 2007, Molecular Neurobiology.
[37] J. Magee,et al. Attenuated LTP in hippocampal dentate gyrus neurons of mice deficient in the PAF receptor. , 2001, Journal of neurophysiology.
[38] F. Mahmoud,et al. In vitro effects of Ginkgolide B on lymphocyte activation in atopic asthma: comparison with cyclosporin A. , 2000, Japanese journal of pharmacology.
[39] D. Warburton. Ginkgo biloba extract and cognitive decline. , 1993, British journal of clinical pharmacology.
[40] K. Drieu,et al. Decreased cerebral 5‐HT1A receptors during ageing: reversal by Ginkgo biloba extract (EGb 761) , 1994, The Journal of pharmacy and pharmacology.
[41] K. Nakanishi,et al. Ginkgolide derivatives for photolabeling studies: preparation and pharmacological evaluation. , 2002, Journal of medicinal chemistry.
[42] K. Nakanishi,et al. The ginkgolides. III. The structure of the ginkgolides , 1967 .
[43] K. Nakanishi,et al. The ginkgolides. V. Some aspects of their NMR spectra , 1967 .
[44] K. Nakanishi,et al. Efficient extraction of ginkgolides and bilobalide from Ginkgo biloba leaves. , 2002, Journal of natural products.
[45] N. Bazan,et al. Platelet-activating factor in the modulation of excitatory amino acid neurotransmitter release and of gene expression. , 1996, Journal of lipid mediators and cell signalling.
[46] F. V. Defeudis,et al. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. , 2000, Current drug targets.
[47] K. Nakanishi,et al. The ginkgolides. I. Isolation and characterization of the various groups , 1967 .
[48] James B. Thomas,et al. Total Synthesis of (.+‐.)‐Ginkgolide B. , 2010 .
[49] F. Huguet,et al. α2‐Adrenoceptor Changes During Cerebral Ageing. The Effect of Ginkgo biloba Extract , 1992, The Journal of pharmacy and pharmacology.
[50] Cytotoxicity of alkylphenols from Ginkgo biloba. , 1999, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[51] C. Benezra,et al. Allergic contact dermatitis to Ginkgo biloba L.: relationship with urushiol , 2004, Archives of Dermatological Research.
[52] Arun K. Ghosh,et al. Total Synthesis of (±)-Ginkgolide B. , 1988, Journal of the American Chemical Society.
[53] I. Hindmarch,et al. The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers , 1999, Phytotherapy research : PTR.